PsychoGenics

PsychoGenics offers a wide range of standard and customized preclinical services. PsychoGenics provides a full complement of partnered discovery capabilities focusing on psychiatric and neurodegenerative disorders, pain and inflammation, spinal cord and traumatic brain injury. PsychoGenics' capabilities include behavioral testing, electrophysiology, molecular biology, state of the art microdialysis and a variety of in-licensed transgenic mouse models (breeding, genotyping, phenotyping). PsychoGenics’ proprietary technologies are developed to facilitate high throughput, in vivo, compound screening. PsychoGenics transforms drug discovery by combining expertise in behavioral neurobiology with the power of bioinformatics in conjunction with proprietary, high-throughput behavioral testing platforms that rapidly screen compound libraries for CNS activity.